SciDEX — RNS

Understanding Entity Pages

This page aggregates everything SciDEX knows about RNS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Target	Relation	Type	Str
NRF2	activates	protein	0.95

Source	Relation	Type	Str
MYELOPEROXIDASE	produces	enzyme	0.85
ABETA	induces	protein	0.80

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Can TREM2 receptor switching from agonism to antagonism be achieved safely witho

neurodegeneration | 2026-04-11 | 0 hypotheses

Do transferred mitochondria from diseased astrocytes carry pathological damage t

neurodegeneration | 2026-04-11 | 0 hypotheses

Can pathological vs physiological C1q tagging be distinguished at the molecular

neurodegeneration | 2026-04-11 | 0 hypotheses

Do SPM receptors undergo desensitization with chronic agonist treatment, prevent

pharmacology | 2026-04-11 | 0 hypotheses

Do tau strains or regional cellular environments primarily drive PSP vs CBD path

neurodegeneration | 2026-04-10 | 0 hypotheses

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

neurodegeneration | 2026-04-09 | 0 hypotheses

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

neurodegeneration | 2026-04-07 | 0 hypotheses

Can chaperone enhancement approaches overcome tau seed saturation effects in adv

protein folding | 2026-04-06 | 0 hypotheses

How do regional, age, and sex-dependent differences in microglial populations af

neuroinflammation | 2026-04-06 | 0 hypotheses

Neuroinflammation and microglial priming in early AD

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.498

How do neurodegeneration gene expression patterns in SEA-AD differ from other po

neurodegeneration | 2026-04-04 | 1 hypotheses Top: 0.448

Human connectome alterations and network-level dysfunction in Alzheimer disease

neurodegeneration | 2026-04-04 | 0 hypotheses

Systemic immune profiling and peripheral immune contributions to neurodegenerati

neurodegeneration | 2026-04-04 | 0 hypotheses

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 17 hypotheses Top: 0.662

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 1 hypotheses Top: 0.502

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.527

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

neurodegeneration | 2026-04-02 | 0 hypotheses

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-02 | 0 hypotheses

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-02 | 0 hypotheses

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas

neurodegeneration | 2026-04-02 | 5 hypotheses Top: 0.519

4R-tau strain-specific spreading patterns in PSP vs CBD

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.507

4R-tau strain-specific spreading patterns in PSP vs CBD

neurodegeneration | 2026-04-01 | 0 hypotheses

RNS

Understanding Entity Pages

Wiki Pages (21)

Responsive Neurostimulation (RNS)

Atypical Parkinsonism

ftd-tdp-pathology

Melatonin for Tauopathy: Comprehensive Evidence Synthesis

Sulforaphane and Nrf2 Activation for Neuroprotection

Blood-Brain Barrier Biology and Crossing Strategies

Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)

uni-pittsburgh

GBA1→GCase→Lysosome→PD Causal Chain

Microglial Senescence Pathway in Neurodegeneration

Autophagy-Lysosomal Impairment Across Neurodegenerative Diseases

Google Ventures (GV)

Neuroinflammation Across AD, PD, ALS, FTD, and HD

Parkinson's Disease Treatment

JAK-STAT Signaling Pathway in Neurodegeneration

alpha-lipoic-acid-neurodegeneration

Remyelination in Neurodegeneration

DNA Damage Response in Alzheimer's Disease

Cellular Senescence in Neurodegeneration

Oxidative Stress in Neurodegeneration

Hippocampal CA3 Pyramidal Neurons in Epilepsy

Outgoing (1)

Incoming (2)

Targeting Hypotheses (0)

Mentioning Analyses (27)

What are the specific molecular determinants that govern tau strain selection du

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

Are age-related static epigenetic patterns pathogenic or protective compensatory

Does human glymphatic function show clinically relevant circadian variation like

Does CXCL10 inhibition compromise CNS immune surveillance during chronic treatme

Can TREM2 receptor switching from agonism to antagonism be achieved safely witho

Do transferred mitochondria from diseased astrocytes carry pathological damage t

Can pathological vs physiological C1q tagging be distinguished at the molecular

Do SPM receptors undergo desensitization with chronic agonist treatment, prevent

Do tau strains or regional cellular environments primarily drive PSP vs CBD path

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

Can chaperone enhancement approaches overcome tau seed saturation effects in adv

How do regional, age, and sex-dependent differences in microglial populations af

Neuroinflammation and microglial priming in early AD

How do neurodegeneration gene expression patterns in SEA-AD differ from other po

Human connectome alterations and network-level dysfunction in Alzheimer disease

Systemic immune profiling and peripheral immune contributions to neurodegenerati

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas

4R-tau strain-specific spreading patterns in PSP vs CBD

4R-tau strain-specific spreading patterns in PSP vs CBD

Related Papers (0)